WeVote
Log In

Bill

Bill

A 1462

Establishes a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients

2025 Regular Session Introduced by Pamela Hunter and 3 co-sponsors

Bill A 1462 mandates Medicaid and private insurers to respond to oncology pre-authorization claims within five business days, ensuring timely access to critical treatments.

REFERRED TO INSURANCE
0
WeVote Research Nonpartisan
Bill Summary · A 1462

Summary of Bill A 1462

Bill Information

  • Bill Number: A 1462
  • Title: Establishes a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients
  • Status: Referred to Insurance
  • Introduced: January 09, 2025
  • Classification: Bill

Purpose and Intent

Bill A 1462 aims to improve the efficiency and timeliness of healthcare delivery for oncology patients by mandating a specific timeframe for insurance providers to respond to pre-authorization requests. The intent is to reduce delays in accessing necessary treatments and tests, which can be critical for cancer patients.

Key Provisions

  • Response Timeframe: The bill requires both Medicaid and private insurers to respond to pre-authorization claims within five business days of submission.
  • Applicability: This mandate applies specifically to claims related to testing and treatments for oncology patients, ensuring that these individuals receive timely care.

Impact

  • Oncology Patients: The primary beneficiaries of this bill will be oncology patients who often face urgent medical needs. Timely responses from insurers can lead to quicker access to necessary treatments, potentially improving health outcomes.
  • Healthcare Providers: Physicians treating oncology patients will have a clearer expectation of when they can expect responses from insurers, allowing for better planning and patient management.
  • Insurance Companies: Insurers will need to adjust their processes to comply with the mandated response time, which may involve changes in staffing or operational procedures.

Procedural Aspects

  • The bill was introduced on January 09, 2025, and has been referred to the Insurance committee for further consideration.
  • It is important to note that this bill has a companion bill, S 586, which may provide additional context or support for its provisions.

Related Bills

  • A 10679: A prior-session bill that may have addressed similar issues regarding pre-authorization processes.
  • S 586: The companion bill in the Senate that aligns with the objectives of A 1462.

This summary provides an overview of Bill A 1462, highlighting its purpose, key provisions, and potential impacts on patients and healthcare providers. The bill seeks to streamline the pre-authorization process for oncology treatments, ultimately aiming to enhance patient care.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.